The value of new U.S. stock listings has only ticked up modestly from 2022, when rapidly rising interest rates and COVID-related distortions in some industries depressed IPO activity.
As of December 31, 2024. Source: Bloomberg Finance L.P.
Showing posts with label 2011 IPOs. Show all posts
Showing posts with label 2011 IPOs. Show all posts
Tuesday, December 31, 2024
Thursday, October 18, 2018
Endocyte (ECYT) to be acquired by Novartis (NVS) for $2.1B
- Endocyte (ECYT) on Thursday announced its $2.1-billion cash sale to Novartis AG (NVS). The deal values Endocyte at $24 per share, representing a 54-percent premium from the firm’s $15.56 Wednesday closing price.
- Endocyte's radioligand portfolio, currently in mid-stage trials for cancer treatment, will supplement Novartis’ oncology pipeline of 33 candidates. Altogether, the buyer boasts 99 candidates in various stages of development.
(Bloomberg) -- Loyal investors who stuck with Endocyte Inc. during a three-and-a-half year slump are celebrating today after a Novartis AG buyout offer sent shares of the cancer drug biotech soaring. But those who lost patience in Endocyte are left to wonder what might have been.
Endocyte rallied more than 1,600 percent in the past 13 months as it advanced its prostate drug candidate -- climaxing on Thursday as Novartis splashed out $2.1 billion on a friendly buyout. The deal came at a 54 percent premium to Wednesday’s close and rewarded a group of sector specialist funds that made big bets on Endocyte, a small Indiana-based drugmaker that’s faced down concern its drug might not be ready for prime time.
The biggest winner was apparently VenBio Select Advisor LLC, known for making bets across the drug discovery landscape and the largest holder with more than 7 percent of Endocyte as of the latest filing period ended June 30. VenBio bought its entire position only in the first quarter, when Endocyte sold for between $3 and $11, according to Bloomberg data. Novartis offered $24 a share for Endocyte today.
Boston-based RA Capital Management bought almost an additional 1.8 million shares in the second quarter, and was the second-largest Endocyte holder as of June 30, filings show.
The value of VenBio and RA Capital’s most recent positions, as reported to the SEC for the second quarter, each rose to about $132 million at Endocyte’s peak on Thursday.
Monday, February 5, 2018
Kosmos Energy (KOS) completed drilling the Requin Tigre-1 exploration well Senegal
Kosmos Energy (KOS) announced that it has completed drilling the Requin Tigre-1 exploration well located in Senegal's Saint Louis Offshore Profond block.
- Requin Tigre-1 was drilled to a total depth of 5,200 meters and was designed to evaluate Cenomanian and Albian reservoirs in a structural-stratigraphic trap, charged from an underlying Neocomian-Valanginian source kitchen.
Kosmos Energy and its partners, British oil giant BP (NYSE: BP) and the national oil company of Senegal, recently finished drilling the Requin Tigre-1 exploration well. However, Kosmos said that after extensive testing, the partners didn't encounter any oil and gas. This dry hole in is the latest in a string of exploration misses for Kosmos since it signed an exploration deal with BP at the end of 2016, only hitting on one of the four wells in the second phase of its program. It was much more successful in the first phase, going 3-for-3 and discovering a major natural gas resource.
Thursday, October 12, 2017
OncoSec Medical (ONCS) to present data at the 9th World Congress of Melanoma
- Headquarters: California
- Founded: 2008
- oncosec.com
OncoSec Medical to Present Updated Clinical and Immune Biomarker Data from its Monotherapy and Combination Therapy Studies with ImmunoPulse IL-12 at the 9th World Congress of Melanoma - A Joint Meeting with the Society for Melanoma Research
Co will present new clinical data on ImmunoPulse IL-12 (intratumoral pIL-12 "tavo" with electroporation), its lead program focused on oncology, at the upcoming 9th World Congress of Melanoma -- A Joint Meeting with the Society for Melanoma Research (SMR). In addition, Chris Twitty, Ph.D., Executive Director of Clinical Science, gave an oral presentation at the 2nd Annual Biomarkers & Precision Medicine USA Congress earlier this week.
"These data, along with the emerging clinical data from the phase 2 combination study, further support the rationale for our global, open-label, registration directed phase 2b clinical trial, PISCES/KEYNOTE-695, which we anticipate reporting initial data in mid-2018."
Sunday, June 7, 2015
Friday, January 27, 2012
NYSE - Global Listings Year in Review 2011
Scott Cutler, EVP and Co-Head of U.S. Listings and Cash Execution at NYSE Euronext, discusses the company's global Listings performance in 2011 and outlook for 2012.
Wednesday, December 28, 2011
Digital Domain Media (DDMG) looks good today
- On September 11, 2012, Digital Domain Media Group Inc. filed for Chapter 11 bankruptcy protection after defaulting on a $35 million loan, and reached a deal to sell its operating businesses – Digital Domain and Mothership—to stalking horse Searchlight Capital Partners, a private investment firm, for $15 million.
*** weekly ***
Monday, December 19, 2011
Zynga (ZNGA) continues to slide on the second day of trading
- ZNGA drops another 5% and is trading below the IPO price of $10
Thursday, December 15, 2011
Bonanza Creek Energy (BCEI)
Bonanza Creek Energy, Inc., incorporated in December 2010, is an oil and natural gas company engaged in the acquisition, exploration, development and production of onshore oil and associated liquids-rich natural gas in the United States. The Company’s assets and operations were focused primarily in southern Arkansas (Mid-Continent region) and the Denver Julesburg (DJ) and North Park Basins in Colorado (Rocky Mountain region) during the year ended December 31, 2010. In addition, it owns and operates oil producing assets in the San Joaquin Basin (California region). It operated approximately 99.4% and held an average working interest of approximately 85.8% of its proved reserves as of December 31, 2010. As of December 31, 2010, its net proved reserves was 32,860 million barrels of oil equivalent (MBoe).
410 17th Street
Suite 1500
Denver, CO 80202
United States
- Founded in 2009
- 71 Employees
- Web : www.bonanzacrk.net
The Denver oil and natural gas company said it plans to raise $195.5 million by selling up to 11.5 million shares at $17 apiece. Earlier this month, Bonanza said it planned to sell those shares at $20 each.
Bonanza said it would use the cash generated from the sale to refinance company debts, and to pay for company operations.
The company owns oil and gas fields in Arkansas, Colorado and California with access to 32.9 million barrels of proven reserves. Its daily production in October was 4,831 barrels of oil equivalent per day. By the end of the year, Bonanza said it will have drilled 115 wells.
Morgan Stanley & Co. and Credit Suisse Securities are listed as joint book-running managers for the offering.
The Company’s proved reserves and its drilling locations in its Mid-Continent acreage are located in the Dorcheat Macedonia field and the McKamie Patton field. In the Dorcheat Macedonia field the Company averages a 83.3% working interest and 68.5% net revenue interest, and all of the Company’s acreage is held by production. It had approximately 78 gross (65.0 net) producing wells and its average net daily production during April 2011, was approximately 1,249 barrels of oil equivalent per day (Boe/d) from a proved reserves base of 15,247 million barrels of oil equivalent, of which about 64.5% was oil and natural gas liquids. As of April 30, 2011, the Company had drilled 13 gross (10.2 net) wells. Immediately northwest of the Dorcheat Macedonia field, it owns and operates the McKamie gas processing facility, which processes all of the gas from the field. It owns additional interests in the Mid-Continent region near the Dorcheat Macedonia field. These include interests in the McKamie-Patton, Atlanta and Beach Creek fields. Its estimated proved reserves in these fields as of December 31, 2010, were approximately 1,947.8 million barrels of oil equivalent, and average net daily production during April 2011, was approximately 239 barrels of oil equivalent per day.
Michael Kors (KORS) started trading on the NYSE on 15 Dec 2011
After pricing at $20 — higher than the expected $17-19 range — Michael Kors shares debuted with a 25 percent pop.
- KORS raised almost $1 billion on its first day of trading
- For the first half of 2011, revenues are up 60%, profit almost doubled
- With under 200 stores in North America, the company projects a potential rollout to 400.
- Internationally, the company has 37 stores in Japan and Europe and is looking for a potential of 100 in each market. You can find Kors products in over 2,000 wholesale points (Harrod's, Saks, Bergdorf)
Michael Kors with his mother Joan outside of the NYSE
Michael Kors Holdings Limited EVP, CFO & COO Joe Parsons; Michael Kors Holdings Limited Director Lawrence Stroll; NYSE Euronext SVP David Ethridge; Michael Kors Holdings Limited Honorary Chairman & Chief Creative Officer Michael Kors; Michael Kors Holdings Limited Director Silas Chou and Michael Kors Holdings Limited Chairman & CEO John Idol ring the NYSE Opening Bell to celebrate the company’s IPO on the NYSE
Michael Kors with husband Lance Lepere outside of the NYSE
my favorite : KORS Michael Kors Lizzie Patent Sandal
Tuesday, December 13, 2011
Wednesday, November 16, 2011
Thursday, November 10, 2011
Imperva raises $85.5m in NYSE IPO
- Update 10/10/18: Private equity firm Thoma Bravo to acquire Imperva in $2.1B buyout.
The data protection solutions developer issued 4.75 million shares, at $18 per share, above its $14-16 target.
Data protection solutions developer Imperva Inc. raised a gross $85.5 million in its IPO on the New York Stock Exchange at a company value of $398 million. The company, founded by president and CEO Shlomo Kramer, issued 4.75 million shares, at $18 per share, above its $14-16 target. The shares will be traded under the symbol "IMPV".
In addition, shareholders sold 250,000 shares for a gross $4.5 million. If the underwriters exercise in full their over-allotment option to buy up to 750,000 shares, the offering will increase by a gross $13.5 million. The offering was based on the company's prospectus filed with the US Securities and Exchange Commission (SEC) yesterday.
Saturday, October 29, 2011
2011 IPO update
- (10/29/11) The IPO pipeline: There are 211 IPOs attempting to raise $52 billion, one of the largest pileups of deals in decades, says Renaissance. There have been just two IPOs since mid-August: a cosmetic medical company, Zeltiq Aesthetics, and wireless networking company, Ubiquiti Networks.
- Zeltiq (ZLTQ) and Ubiquiti Networks cut their price ranges 13% and 29%, respectively, from their original ranges, which made them more appealing to investors. Both deals are up more than 15% from their IPO prices.
- USA: Only 98 IPO deals priced so far this year, with 28 of them from small companies
- Globally: In the third quarter of this year there were 284 Initial Public Offerings. The Asia Pacific region accounted for 57% of these IPOs (source: Ernst & Young)
- 215 IPOs have been withdrawn or postponed globally so far this year (as of 9/11)
Top underwriters:
- Goldman Sachs: 6.8% market share, 39 deals (as of 9/11)
- Morgan Stanley" 6% market share, 50 deals (as of 9/11)
Sunday, September 18, 2011
Skullcandy (SKUL) looks like a buy
- Skullcandy was acquired by Mill Road Capital for $196.9 million or $6.35 per share in 2016.
Skullcandy, Inc., incorporated in 2003, develops and distributes headphones and other audio accessories to retailers throughout the United States and to distributors in various countries worldwide. The Company is an audio brand that reflects the collision of the music, fashion and action sports lifestyles. The Company is engaged in the distribution of headphones in specialty retailers focused on action sports and the youth lifestyle, such as Zumiez, Tilly’s and hundreds of independent snow, skate and surf retailers. It distributes through consumer electronics, mass, sporting goods and mobile phone retailers, such as Best Buy, Target, Dick’s Sporting Goods and AT&T Wireless. Skullcandy products are also sold through its Website. As of September 30, 2010, its product offering had over 1,200 SKUs across a range of categories, including headphones as well as speaker docks, mobile device cases, apparel and other accessories. Its headphone products include in ear, on ear, over ear and gaming. In August 2011, the Company acquired Kungsbacka 57 AB.
The Company’s product line include dB Collecti; Mobility Collectio, which targets mobile channel with product features designed to work on cell phones and smartphones, such as the Apple iPhone, and 2XL, which represents traditional sports, motor sports and rock and roll music. The Company sponsors athletes, disc jockeys (DJs), musicians, artists and events within all areas of action sports and the indie and hip-hop music genres. Through its Websites, skullcandy.com and skullcandy.tv visitors can view videos, listen to music by its sponsored artists, read blog updates on events, athletes, DJs, musicians and artists, and shop for its products. In August 2010, the Company entered into a three-year contract with UPS Supply Chain Solutions, a third party supply chain provider, for use of their distribution facility in Auburn, Washington.
The Company competes with Sony, JVC, Bose, Beats by Dr. Dre, Nixon, adidas, Nike, Sennheiser and Phillips.
Wednesday, August 31, 2011
2011 largest IPOs - by market cap
(Links go to Google Finance)
Name | Symbol | Last price on 8/31/11 | Market Cap |
25.85 | 20.92B | ||
29.66 | 10.64B | ||
20.03 | 10.36B | ||
30.97 | 10.00B | ||
84.12 | 8.10B | ||
27.57 | 5.78B | ||
13.88 | 5.41B | ||
41.84 | 3.37B | ||
26.34 | 3.33B | ||
7.34 | 2.88B | ||
11.50 | 2.82B | ||
23.80 | 2.77B | ||
24.20 | 2.51B | ||
22.81 | 2.30B | ||
23.45 | 2.28B | ||
13.20 | 2.13B | ||
25.04 | 1.95B | ||
24.33 | 1.78B | ||
16.65 | 1.66B | ||
13.26 | 1.41B | ||
13.80 | 1.41B | ||
27.10 | 1.28B | ||
26.14 | 1.24B | ||
18.07 | 1.23B | ||
10.62 | 1.16B | ||
12.31 | 1.05B | ||
25.71 | 1.00B | ||
37.18 | 1.00B | ||
22.93 | 998.05M | ||
14.16 | 991.20M | ||
25.95 | 987.15M | ||
12.94 | 924.94M | ||
23.39 | 916.21M | ||
16.18 | 889.90M | ||
12.08 | 875.71M | ||
14.01 | 835.97M | ||
9.73 | 827.24M | ||
12.56 | 824.17M | ||
21.03 | 820.95M | ||
20.12 | 790.39M | ||
15.52 | 745.96M | ||
26.06 | 729.68M | ||
8.65 | 725.99M | ||
23.44 | 708.00M | ||
14.56 | 685.13M | ||
12.91 | 611.46M | ||
23.99 | 466.60M | ||
16.54 | 446.13M | ||
10.96 | 389.83M | ||
22.34 | 375.87M | ||
22.99 | 365.98M | ||
8.96 | 357.54M | ||
11.07 | 347.55M | ||
21.40 | 316.37M | ||
8.45 | 316.06M | ||
14.50 | 299.67M | ||
8.75 | 289.99M | ||
7.37 | 289.32M | ||
10.67 | 276.96M | ||
13.49 | 269.70M | ||
5.05 | 260.63M | ||
6.62 | 239.23M | ||
8.28 | 225.86M | ||
5.92 | 204.37M | ||
18.43 | 185.24M | ||
17.75 | 182.29M | ||
18.20 | 182.11M | ||
10.76 | 171.01M | ||
7.42 | 157.32M | ||
9.72 | 156.62M | ||
8.00 | 153.18M | ||
6.10 | 150.95M | ||
15.51 | 143.60M | ||
7.66 | 132.01M | ||
6.04 | 116.65M | ||
2.96 | 108.36M | ||
12.02 | 107.68M | ||
3.01 | 83.32M | ||
3.10 | 73.50M | ||
3.40 | 66.03M | ||
6.14 | 56.27M | ||
3.20 | 50.35M | ||
0.0000* | 41.00M | ||
7.05* | 36.46M | ||
5.82 | 17.20M |
Subscribe to:
Posts (Atom)